TY - JOUR AU - Henshall, C. AU - Mardhani-Bayne, L. AU - Fronsdal, K. B. AU - Klemp, M. PY - 2011 DA - 2011// TI - Interactions between health technology assessment, coverage, and regulatory processes: emerging issues, goals, and opportunities JO - Int J Technol Assess Health Care VL - 27 UR - https://doi.org/10.1017/S0266462311000262 DO - 10.1017/S0266462311000262 ID - Henshall2011 ER - TY - JOUR AU - Hutton, J. AU - McGrath, C. AU - Frybourg, J. M. AU - Tremblay, M. AU - Bramley-Harker, E. AU - Henshall, C. PY - 2006 DA - 2006// TI - Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems) JO - Int J Technol Assess Health Care VL - 22 UR - https://doi.org/10.1017/S0266462306050781 DO - 10.1017/S0266462306050781 ID - Hutton2006 ER - TY - STD TI - Organisation for Economic Co-operation and Development. Health at a Glance 2013. OECD Indicators. 2013. http://www.oecd.org/health/health-systems/health-at-a-glance.htm. UR - http://www.oecd.org/health/health-systems/health-at-a-glance.htm ID - ref3 ER - TY - STD TI - Carone G, Schwierz C, Xavier A. Cost-containment policies in public pharmaceutical spending in the EU. European Economy. Economic Papers 461. Brussels: European Commission; 2012. ec.europa.eu/economy_finance/publications/…/ecp_461_en.pdf. ID - ref4 ER - TY - STD TI - Sorenson C, Drummond M, Kanavos P. Ensuring value for money in health care: the role of health technology assessment in the European Union. European Observatory on Health Systems and Policies: Copenhagen; 2008. ID - ref5 ER - TY - JOUR AU - Luce, B. R. AU - Drummond, M. AU - Jonsson, B. AU - Neumann, P. J. AU - Schwartz, J. S. AU - Siebert, U. PY - 2010 DA - 2010// TI - EBM, HTA, and CER: clearing the confusion JO - Milbank Q VL - 88 UR - https://doi.org/10.1111/j.1468-0009.2010.00598.x DO - 10.1111/j.1468-0009.2010.00598.x ID - Luce2010 ER - TY - BOOK AU - Zentner, A. AU - Velasco-Garrido, M. AU - Busse, R. PY - 2011 DA - 2011// TI - Aktuelle internationale Initiativen der evidenzbasierten Berwetung von Arzneimitteln. vol. 6. pp. III-63 PB - TU Berlin University Press CY - Berlin, Germany ID - Zentner2011 ER - TY - JOUR AU - Mauskopf, J. AU - Walter, J. AU - Birt, J. AU - Bowman, L. AU - Copley-Merriman, C. AU - Drummond, M. PY - 2011 DA - 2011// TI - Differences among formulary submission guidelines: implications for health technology assessment JO - Int J Technol Assess Health Care VL - 27 UR - https://doi.org/10.1017/S0266462311000274 DO - 10.1017/S0266462311000274 ID - Mauskopf2011 ER - TY - JOUR AU - Kleijnen, S. AU - George, E. AU - Goulden, S. AU - d’Andon, A. AU - Vitre, P. AU - Osinska, B. PY - 2012 DA - 2012// TI - Relative effectiveness assessment of pharmaceuticals: similarities and differences in 29 jurisdictions JO - Value Health VL - 15 UR - https://doi.org/10.1016/j.jval.2012.04.010 DO - 10.1016/j.jval.2012.04.010 ID - Kleijnen2012 ER - TY - JOUR AU - Riedel, R. AU - Repschlager, U. AU - Griebenow, R. AU - Breitkopf, S. AU - Schmidt, S. AU - Guhl, A. PY - 2013 DA - 2013// TI - International standards for health economic evaluation with a focus on the German approach JO - J Clin Pharm Ther VL - 38 UR - https://doi.org/10.1111/jcpt.12043 DO - 10.1111/jcpt.12043 ID - Riedel2013 ER - TY - JOUR AU - Spinner, D. S. AU - Birt, J. AU - Walter, J. W. AU - Bowman, L. AU - Mauskopf, J. AU - Drummond, M. F. PY - 2013 DA - 2013// TI - Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions JO - Clinicoecon Outcomes Res VL - 5 ID - Spinner2013 ER - TY - JOUR AU - Cleemput, I. AU - Franken, M. AU - Koopmanschap, M. AU - Polain, M. PY - 2012 DA - 2012// TI - European drug reimbursement systems’ legitimacy: five-country comparison and policy tool JO - Int J Technol Assess Health Care VL - 28 UR - https://doi.org/10.1017/S0266462312000529 DO - 10.1017/S0266462312000529 ID - Cleemput2012 ER - TY - JOUR AU - Franken, M. AU - Polain, M. AU - Cleemput, I. AU - Koopmanschap, M. PY - 2012 DA - 2012// TI - Similarities and differences between five European drug reimbursement systems JO - Int J Technol Assess Health Care VL - 28 UR - https://doi.org/10.1017/S0266462312000530 DO - 10.1017/S0266462312000530 ID - Franken2012 ER - TY - JOUR AU - Stafinski, T. AU - Menon, D. AU - Davis, C. AU - McCabe, C. PY - 2011 DA - 2011// TI - Role of centralized review processes for making reimbursement decisions on new health technologies in Europe JO - Clinicoecon Outcomes Res VL - 3 UR - https://doi.org/10.2147/CEOR.S14407 DO - 10.2147/CEOR.S14407 ID - Stafinski2011 ER - TY - JOUR AU - Allen, N. AU - Pichler, F. AU - Wang, T. AU - Patel, S. AU - Salek, S. PY - 2013 DA - 2013// TI - Development of archetypes for non-ranking classification and comparison of European National Health Technology Assessment systems JO - Health Policy VL - 113 UR - https://doi.org/10.1016/j.healthpol.2013.09.007 DO - 10.1016/j.healthpol.2013.09.007 ID - Allen2013 ER - TY - JOUR AU - Barnieh, L. AU - Manns, B. AU - Harris, A. AU - Blom, M. AU - Donaldson, C. AU - Klarenbach, S. PY - 2014 DA - 2014// TI - A synthesis of drug reimbursement decision-making processes in organisation for economic co-operation and development countries JO - Value Health VL - 17 UR - https://doi.org/10.1016/j.jval.2013.10.008 DO - 10.1016/j.jval.2013.10.008 ID - Barnieh2014 ER - TY - JOUR AU - Fischer, K. E. AU - Leidl, R. PY - 2014 DA - 2014// TI - Analysing coverage decision-making: opening Pandora’s box? JO - Eur J Health Econ VL - 15 UR - https://doi.org/10.1007/s10198-014-0566-8 DO - 10.1007/s10198-014-0566-8 ID - Fischer2014 ER - TY - JOUR AU - Towse, A. AU - Barnsley, P. PY - 2013 DA - 2013// TI - Approaches to identifying, measuring, and aggregating elements of value JO - Int J Technol Assess Health Care VL - 29 UR - https://doi.org/10.1017/S0266462313000524 DO - 10.1017/S0266462313000524 ID - Towse2013 ER - TY - JOUR AU - Henshall, C. AU - Schuller, T. PY - 2013 DA - 2013// TI - Health technology assessment, value-based decision making, and innovation JO - Int J Technol Assess Health Care VL - 29 UR - https://doi.org/10.1017/S0266462313000378 DO - 10.1017/S0266462313000378 ID - Henshall2013 ER - TY - JOUR AU - Rogowski, W. H. AU - Hartz, S. C. AU - John, J. H. PY - 2008 DA - 2008// TI - Clearing up the hazy road from bench to bedside: a framework for integrating the fourth hurdle into translational medicine JO - BMC Health Serv Res VL - 8 UR - https://doi.org/10.1186/1472-6963-8-194 DO - 10.1186/1472-6963-8-194 ID - Rogowski2008 ER - TY - STD TI - Zentner A, Busse R. Bewertung von Arzneimitteln – wie gehen andere Länder vor? G+G Wissenschaft. 2011;11:25–34. ID - ref21 ER - TY - JOUR AU - Kristensen, F. B. AU - Makela, M. AU - Neikter, S. A. AU - Rehnqvist, N. AU - Haheim, L. L. AU - Morland, B. PY - 2009 DA - 2009// TI - European network for health technology assessment, EUnetHTA: planning, development, and implementation of a sustainable European network for health technology assessment JO - Int J Technol Assess Health Care VL - 25 UR - https://doi.org/10.1017/S0266462309990754 DO - 10.1017/S0266462309990754 ID - Kristensen2009 ER - TY - JOUR AU - Rogowski, W. H. PY - 2013 DA - 2013// TI - An economic theory of the fourth hurdle JO - Health Econ VL - 22 UR - https://doi.org/10.1002/hec.2830 DO - 10.1002/hec.2830 ID - Rogowski2013 ER - TY - JOUR AU - Drummond, M. AU - Jonsson, B. AU - Rutten, F. AU - Stargardt, T. PY - 2011 DA - 2011// TI - Reimbursement of pharmaceuticals: reference pricing versus health technology assessment JO - Eur J Health Econ VL - 12 UR - https://doi.org/10.1007/s10198-010-0274-y DO - 10.1007/s10198-010-0274-y ID - Drummond2011 ER - TY - JOUR AU - Vandoros, S. AU - Stargardt, T. PY - 2013 DA - 2013// TI - Reforms in the Greek pharmaceutical market during the financial crisis JO - Health Policy VL - 109 UR - https://doi.org/10.1016/j.healthpol.2012.08.016 DO - 10.1016/j.healthpol.2012.08.016 ID - Vandoros2013 ER - TY - BOOK AU - Busse, R. AU - Panteli, D. AU - Henschke, C. PY - 2015 DA - 2015// TI - Arzneimittelversorgung in der GKV und 15 anderen europäischen Gesundheitssystemen: ein systematischer Vergleich. vol. 11 PB - TU Berlin University Press CY - Berlin, Germany ID - Busse2015 ER - TY - JOUR AU - Fischer, K. E. AU - Rogowski, W. H. AU - Leidl, R. AU - Stollenwerk, B. PY - 2013 DA - 2013// TI - Transparency vs. closed-door policy: do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis JO - Health Policy VL - 112 UR - https://doi.org/10.1016/j.healthpol.2013.04.011 DO - 10.1016/j.healthpol.2013.04.011 ID - Fischer2013 ER - TY - JOUR AU - Kreis, J. AU - Panteli, D. AU - Busse, R. PY - 2014 DA - 2014// TI - How health technology assessment agencies address the issue of unpublished data JO - Int J Technol Assess Health Care VL - 30 UR - https://doi.org/10.1017/S026646231300072X DO - 10.1017/S026646231300072X ID - Kreis2014 ER - TY - JOUR AU - Fischer, K. E. AU - Stollenwerk, B. AU - Rogowski, W. H. PY - 2013 DA - 2013// TI - Link between process and appraisal in coverage decisions: an analysis with structural equation modeling JO - Med Decis Making VL - 33 UR - https://doi.org/10.1177/0272989X13490837 DO - 10.1177/0272989X13490837 ID - Fischer2013 ER - TY - JOUR AU - Sorenson, C. AU - Drummond, M. AU - Burns, L. R. PY - 2013 DA - 2013// TI - Evolving reimbursement and pricing policies for devices in Europe and the United States should encourage greater value JO - Health Aff (Millwood) VL - 32 UR - https://doi.org/10.1377/hlthaff.2012.1210 DO - 10.1377/hlthaff.2012.1210 ID - Sorenson2013 ER -